Hartford Great Health Corp. Files 10-Q for Period Ending January 31, 2024

TL;DR

<b>Hartford Great Health Corp. filed its quarterly report (10-Q) for the period ending January 31, 2024.</b>

AI Summary

Hartford Great Health Corp. (HFUS) filed a Quarterly Report (10-Q) with the SEC on March 14, 2024. Hartford Great Health Corp. filed a 10-Q report on March 14, 2024. The report covers the fiscal period ending January 31, 2024. The company was formerly known as Photoamigo, Inc., with a name change on January 28, 2010. The company is incorporated in Nevada (NV). The filing is for the fiscal quarter ending January 31, 2024.

Why It Matters

For investors and stakeholders tracking Hartford Great Health Corp., this filing contains several important signals. This filing provides an update on the company's financial performance and position for the specified quarter. Understanding the details of this 10-Q is crucial for investors and stakeholders to assess the company's current health and future prospects.

Risk Assessment

Risk Level: — Hartford Great Health Corp. shows moderate risk based on this filing. The filing is a standard 10-Q, indicating routine financial reporting without immediate red flags.

Analyst Insight

Review the financial statements and management's discussion and analysis within the 10-Q to understand the company's operational and financial status.

Key Numbers

• 2024-01-31 — Period End Date (Conformed period of report)
• 2024-03-14 — Filing Date (Filed as of date)
• 2010-01-28 — Name Change Date (Date of former company name change)

Key Players & Entities

• Hartford Great Health Corp. (company) — Filer name
• Photoamigo, Inc. (company) — Former company name
• 2024-01-31 (date) — Period of report
• 2024-03-14 (date) — Filing date
• NV (location) — State of incorporation
• 7374 (sic_code) — Standard Industrial Classification code

FAQ

Industry Context

The company operates within the Services-Computer Processing & Data Preparation industry (SIC code 7374).

Regulatory Implications

The filing is made under the Securities Exchange Act of 1934.

What Investors Should Do

1. Analyze the financial statements (balance sheet, income statement, cash flow) for the quarter ending January 31, 2024.
2. Review the Management's Discussion and Analysis of Financial Condition and Results of Operations for insights into performance drivers and trends.
3. Check for any new disclosures or updates regarding business operations, risks, or legal proceedings.

Key Dates

• 2024-01-31: Quarterly Period End — End of the reporting period for the 10-Q filing.
• 2024-03-14: Filing Date — Date the 10-Q report was officially submitted to the SEC.

Year-Over-Year Comparison

This is a 10-Q filing, which is a standard quarterly report. No prior filing data is provided for comparison.

Key Financial Figures

• $0.001 — ch registered Common stock, par value $0.001 par value HFUS OTC Markets Group

Filing Documents

• form10-q.htm (10-Q) — 428KB
• ex31-1.htm (EX-31.1) — 15KB
• ex31-2.htm (EX-31.2) — 15KB
• ex32-1.htm (EX-32.1) — 6KB
• 0001493152-24-009931.txt (&nbsp;) — 2373KB
• hfus-20240131.xsd (EX-101.SCH) — 18KB
• hfus-20240131_cal.xml (EX-101.CAL) — 30KB
• hfus-20240131_def.xml (EX-101.DEF) — 84KB
• hfus-20240131_lab.xml (EX-101.LAB) — 178KB
• hfus-20240131_pre.xml (EX-101.PRE) — 136KB
• form10-q_htm.xml (XML) — 222KB

Management's Discussion and Analysis or Plan of Operation

Management's Discussion and Analysis or Plan of Operation 12 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 15 Item 4.

Controls and Procedures

Controls and Procedures 15

- OTHER INFORMATION

Part II - OTHER INFORMATION 16 Item 1.

Legal Proceedings

Legal Proceedings 16 Item 1A.

Risk Factors

Risk Factors 16 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 16 Item 3. Defaults Upon Senior Securities 16 Item 4. Mine Safety Disclosures 16 Item 5. Other Information 16 Item 6. Exhibits 16

SIGNATURES

SIGNATURES 17 2 HARTFORD GREAT HEALTH CORP. CONDENSED CONSOLIDATED BALANCE SHEETS January 31, 2024 July 31, 2023 (Unaudited) ASSETS Current Assets Cash and cash equivalents $ 8,484 $ 5,793 Prepaid and Other current receivables 282 280 Related party receivable 964 964 Total Current Assets 9,730 7,037 Non-current Assets Property and equipment, net 597 730 Total Non-current Assets 597 730 TOTAL ASSETS $ 10,327 $ 7,767 LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities Related party loan and payables $ 4,440,337 $ 4,367,194 Other current payable 131,835 130,279 Total Current Liabilities 4,572,172 4,497,473 TOTAL LIABILITIES 4,572,172 4,497,473 Commitments and contingencies - - Stockholders' Equity (Deficit) Preferred stock - $ 0.001 par value, 5,000,000 shares authorized, no shares issued and outstanding - - Common stock - $ 0.001 par value, 300,000,000 shares authorized, 100,108,000 shares outstanding at both of January 31, 2024 and July 31, 2023. 100,108 100,108 Additional paid-in capital 2,173,521 2,173,521 Accumulated deficit ( 7,049,170 ) ( 7,003,717 ) Accumulated other comprehensive income 213,696 240,382 Total Stockholders' Deficit ( 4,561,845 ) ( 4,489,706 ) TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 10,327 $ 7,767 The accompanying notes are an integral part of these condensed consolidated unaudited financial statements. 3 HARTFORD GREAT HEALTH CORP. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) 2024 2023 2024 2023 Three months ended Six months ended January 31, January 31, 2024 2023 2024 2023 Revenue - Related Party $ 62,443 $ - $ 62,443 $ - Cost of revenue - Related Party 55,505 - 55,505 - Gross Profit 6,938 - 6,938 - Operating expenses Selling, general and administrative 21,942 21,362 42,134 76,010 Total operating expenses 21,942 21,362 42,134 76,010 Operating Loss ( 15,004 ) (

View Full Filing

View this 10-Q filing on SEC EDGAR